Highlights Aptorum Group Limited

Equities

APM

KYG6096M1226

Market Closed - Nasdaq Other stock markets 04:30:00 2024-07-05 pm EDT			5-day change	1st Jan Change
3.89 ^USD	-1.52%		-11.22%	+58.87%

Apr. 30	Aptorum Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 06	Top Midday Gainers	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Aptorum Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30	CI
YOOV Group Holding Limited entered into a entered into an Agreement and Plan of Merger to acquire Aptorum Group Limited for $250 million in a reverse merger transaction.	Mar. 05	CI
Aptorum Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	Dec. 22	CI
Aptorum Group Obtains Nasdaq Authorization to Transfer Listing to Nasdaq Capital Market	23-08-10	MT
Aptorum Group Limited Provides Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma	23-06-22	CI
Aptorum Group Gets Non-Compliance Notice From Nasdaq -- Shares Slump in Premarket	23-05-08	MT
Aptorum Group Gets Non-Compliance Notice From Nasdaq	23-05-08	MT
Aptorum Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Aptorum, URF Holding Group to Combine in Reverse Takeover	23-03-27	MT
URF Holding Group Limited entered into a non-binding Letter of Intent and Term Sheet to acquire Aptorum Group Limited for $40 million in a reverse merger transaction.	23-03-26	CI
Aptorum Group Completes US FDA Meetings for ALS-4, SACT-1	23-03-03	MT
Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on Its ALS-4	23-03-03	CI
Aptorum Group Announces Completion of End of Phase 1 Meeting with US FDA on Its Sact-1	23-03-03	CI
Aptorum Group Launches NativusWell, a Novel Nutraceutical for Menopause, in China	23-03-02	CI
Aptorum Group Regains Compliance With Nasdaq Minimum Bid Price Rule But Gets New Deficiency Notice	23-02-13	MT
Aptorum Group Sets 1-for-10 Reverse Stock Split for Monday; Shares Rise Pre-Bell	23-01-20	MT
Aptorum Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-30	CI
Aptorum Group Limited Updates on the Clinical Validation of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics	22-09-15	CI
Aptorum Group Limited Launches NativusWell, a Novel Nutraceutical for Menopause, in Hong Kong	22-09-15	CI
Aptorum Group Limited Updates on Data from Completed Phase 1 Clinical Trial of SACT-1, Targeting Neuroblastoma	22-05-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Aptorum Group Limited

Equities

APM

KYG6096M1226

Highlights

Filters